Thrombocytopenia in ICU Patients

Causes of Thrombocytopenia

• Antimitotic chemotherapies can affect platelet production, leading to thrombocytopenia in patients, according to the American Society of Anesthesiologists 1
• Heparin-induced thrombocytopenia (HIT) typically occurs 5-10 days after heparin initiation, as recommended by the American College of Chest Physicians 2
• Post-transfusion purpura can cause a sudden decrease in platelets, often presenting with hemorrhagic context, as noted by the American Association of Blood Banks 1
• GPIIb-IIIa glycoprotein inhibitors can cause early and profound thrombocytopenia, as reported by the American Heart Association 1
• Disseminated intravascular coagulation (DIC) is often associated with sepsis, leading to thrombocytopenia, according to the Society of Critical Care Medicine 1
• Thrombotic microangiopathies (TMA), including thrombotic thrombocytopenic purpura (TTP), can cause thrombocytopenia, as recommended by the National Institutes of Health 1
• Consumption thrombocytopenia can occur after cardiac surgery, as noted by the American College of Cardiology 1
• Ventricular assistance devices and extracorporeal membrane oxygenation (ECMO) can cause platelet consumption, leading to thrombocytopenia, according to the Extracorporeal Life Support Organization 1
• Perioperative hemodilution from massive fluid resuscitation can cause dilutional thrombocytopenia, as reported by the American Society of Anesthesiologists 1
• Antiphospholipid syndrome can present with both thrombocytopenia and thrombosis, as recommended by the American College of Rheumatology 1

Diagnostic Approach

• The 4T score can be used to evaluate suspected HIT, assessing thrombocytopenia severity, timing, thrombosis, and other potential causes, according to the American College of Chest Physicians 1
• Early thrombocytopenia (within the first 2 days) may be due to the direct effect of unfractionated heparin, hemodilution, or early HIT, as noted by the American Society of Anesthesiologists 1

Common Pitfalls

• Missing HIT diagnosis can lead to delayed heparin discontinuation, as recommended by the American College of Chest Physicians 1
• Failing to consider that some conditions (HIT, antiphospholipid syndrome, TTP) can present with both thrombocytopenia and thrombosis, according to the American Heart Association 1
• Overlooking drug-induced causes of thrombocytopenia is common in ICU patients on multiple medications, as reported by the American Society of Health-System Pharmacists 1

Diagnosis and Management of Pseudothrombocytopenia vs Hemodilution

Introduction to Pseudothrombocytopenia and Hemodilution

• The American Society of Anesthesiologists notes that hemodilution perioperative by massive fluid resuscitation causes real dilutional thrombocytopenia, representing a true decrease in circulating platelet count 3
• Hemodilution typically occurs in surgical contexts, especially cardiac surgery, extracorporeal circuits, intra-aortic balloon counterpulsation, and ventricular assist devices 3, 4

Diagnostic Evaluation

• The American College of Cardiology recommends identifying specific precipitating factors for hemodilution, including recent surgery with massive fluid replacement 3, use of extracorporeal circuits 4, and resuscitation with crystalloids or colloids in trauma or sepsis 4
• Distinguish hemodilution from thrombocytopenia due to consumption or immune-mediated heparin-induced thrombocytopenia (HIT), as hemodilution occurs immediately during or after fluid resuscitation, whereas HIT typically occurs 5-10 days after heparin initiation 3, 4

Management of Hemodilution

• Evaluate the risk of bleeding based on the absolute platelet count, with >50 × 10³/μL generally being asymptomatic, 20-50 × 10³/μL possibly presenting with mild cutaneous manifestations, and <10 × 10³/μL indicating a high risk of severe bleeding 3, 4
• Transfuse platelets only when there is active bleeding, a count <10 × 10³/μL, or before invasive procedures with a count <50 × 10³/μL 3, 4